Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €89.15 EUR
Change Today -3.12 / -3.38%
Volume 5.6M
As of 11:37 AM 05/29/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Anne Clem Whitaker

Former President of North America Pharmaceuticals, Sanofi
AgeTotal Calculated CompensationThis person is connected to 14 board members in 2 different organizations across 4 different industries.

See Board Relationships
47--

Background*

Ms. Anne Clem Whitaker has been Executive Vice President and Group Chairman at Valeant Pharmaceuticals International, Inc. since April 2015. Ms. Whitaker served as the Chief Executive Officer, President at Synta Pharmaceuticals Corp since September 02, 2014. Ms. Whitaker served as President of North America Pharmaceuticals at Sanofi since September 1, 2011. She oversaw all pharmaceutical and consumer healthcare operations within the region, including the Diabetes, Oncology, ...

Read Full Background

Corporate Headquarters*

54, Rue La Boétie
Paris, Ile-de-France 75008

France

Phone: 33 1 53 77 40 00
Fax: 33 1 53 77 42 96

Board Members Memberships*

Vice Chairman and Member of Executive Committee
2013-Present
Director, Member of Governance & Nominations Committee and Member of Compensation Committee
2014-2015
Former Chief Executive Officer, President and Director

Education*

Bachelor's Degree
University Of North Alabama
BBA
University Of North Alabama

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SAN:FP €89.15 EUR -3.12

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$916.0K
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Actavis plc
$500.0K
Dilip Shantilal Shanghvi Managing Director, Executive Director and Member of Shareholders/Investors Grievance Committee
Sun Pharmaceutical Industries Limited
23.1M
Heather Bresch Chief Executive Officer, Executive Director and Member of Science & Technology Committee
Mylan N.V.
$1.2M
Yoshihiko Hatanaka Chief Executive Officer, President and Representative Director
Astellas Pharma, Inc.
¥170.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SANOFI, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.